Johan van Meerloo

3.6k total citations · 1 hit paper
24 papers, 2.7k citations indexed

About

Johan van Meerloo is a scholar working on Molecular Biology, Hematology and Oncology. According to data from OpenAlex, Johan van Meerloo has authored 24 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 10 papers in Hematology and 8 papers in Oncology. Recurrent topics in Johan van Meerloo's work include Ubiquitin and proteasome pathways (17 papers), Multiple Myeloma Research and Treatments (9 papers) and Protein Degradation and Inhibitors (9 papers). Johan van Meerloo is often cited by papers focused on Ubiquitin and proteasome pathways (17 papers), Multiple Myeloma Research and Treatments (9 papers) and Protein Degradation and Inhibitors (9 papers). Johan van Meerloo collaborates with scholars based in Netherlands, Israel and United States. Johan van Meerloo's co-authors include Jacqueline Cloos, Gertjan J.L. Kaspers, Gerrit Jansen, Sonja Zweegman, Yehuda G. Assaraf, Christopher J. Kirk, Denise Niewerth, Aaron D. Schimmer, N. Franke and Janet L. Anderl and has published in prestigious journals such as Blood, Clinical Cancer Research and International Journal of Cancer.

In The Last Decade

Johan van Meerloo

23 papers receiving 2.7k citations

Hit Papers

Cell Sensitivity Assays: The MTT Assay 2011 2026 2016 2021 2011 500 1000 1.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Cell Sensitivity Assays: The MTT Assay
    2011 1.9k citations Johan van Meerloo, Gertjan J.L. Kaspers et al. Methods in molecular biology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Johan van Meerloo Netherlands 15 1.3k 479 349 332 229 24 2.7k
Xuan Zhang China 39 2.4k 1.9× 836 1.7× 279 0.8× 292 0.9× 205 0.9× 160 4.0k
Lin Yang China 28 1.6k 1.2× 340 0.7× 155 0.4× 170 0.5× 201 0.9× 96 3.0k
Gianni Colotti Italy 34 1.5k 1.1× 507 1.1× 656 1.9× 89 0.3× 191 0.8× 99 3.3k
Yue Wang China 27 895 0.7× 425 0.9× 246 0.7× 319 1.0× 126 0.6× 137 2.2k
Takahiro Mori Japan 39 2.6k 2.0× 883 1.8× 671 1.9× 191 0.6× 385 1.7× 165 4.9k
Huanjie Yang China 32 2.0k 1.6× 721 1.5× 281 0.8× 136 0.4× 505 2.2× 57 3.8k
Ann H. Cory United States 14 1.1k 0.8× 609 1.3× 439 1.3× 79 0.2× 196 0.9× 35 2.5k
Anup K. Singh India 27 1.9k 1.4× 478 1.0× 91 0.3× 139 0.4× 298 1.3× 70 2.8k
Vito Ferro Australia 31 1.8k 1.3× 196 0.4× 1.0k 2.9× 210 0.6× 300 1.3× 120 3.1k
Steve Weitman United States 23 1.2k 0.9× 538 1.1× 251 0.7× 157 0.5× 151 0.7× 36 2.5k

Countries citing papers authored by Johan van Meerloo

Since Specialization
Citations

This map shows the geographic impact of Johan van Meerloo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Johan van Meerloo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Johan van Meerloo more than expected).

Fields of papers citing papers by Johan van Meerloo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Johan van Meerloo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Johan van Meerloo. The network helps show where Johan van Meerloo may publish in the future.

Co-authorship network of co-authors of Johan van Meerloo

This figure shows the co-authorship network connecting the top 25 collaborators of Johan van Meerloo. A scholar is included among the top collaborators of Johan van Meerloo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Johan van Meerloo. Johan van Meerloo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hamburg, Jan Piet van, Johan van Meerloo, Judy R. van Beijnum, et al.. (2025). Unveiling the Anti-Angiogenic Potential of Small-Molecule (Kinase) Inhibitors for Application in Rheumatoid Arthritis. Cells. 14(2). 102–102. 1 indexed citations
2.
Jansen, Gerrit, Yehuda G. Assaraf, Sarah Kammerer, et al.. (2023). Statins markedly potentiate aminopeptidase inhibitor activity against (drug-resistant) human acute myeloid leukemia cells. Cancer Drug Resistance. 6(2). 430–446. 5 indexed citations
3.
Cloos, Jacqueline, Robin Beekhof, Sander R. Piersma, et al.. (2020). Phosphotyrosine-based Phosphoproteomics for Target Identification and Drug Response Prediction in AML Cell Lines. Molecular & Cellular Proteomics. 19(5). 884–899. 30 indexed citations
4.
Steen, Nele Van Der, Kaylee M. Keller, Henk Dekker, et al.. (2020). Crizotinib sensitizes the erlotinib resistant HCC827GR5 cell line by influencing lysosomal function. Journal of Cellular Physiology. 235(11). 8085–8097. 7 indexed citations
5.
Krejcik, Jakub, Inger S. Nijhof, Berris van Kessel, et al.. (2017). Monocytes and Granulocytes Reduce CD38 Expression Levels on Myeloma Cells in Patients Treated with Daratumumab. Clinical Cancer Research. 23(24). 7498–7511. 119 indexed citations
6.
Cloos, Jacqueline, N. Franke, Johan van Meerloo, et al.. (2017). (Immuno)proteasomes as therapeutic target in acute leukemia. Cancer and Metastasis Reviews. 36(4). 599–615. 27 indexed citations
7.
Niewerth, Denise, Gertjan J.L. Kaspers, Gerrit Jansen, et al.. (2016). Proteasome subunit expression analysis and chemosensitivity in relapsed paediatric acute leukaemia patients receiving bortezomib-containing chemotherapy. Journal of Hematology & Oncology. 9(1). 82–82. 21 indexed citations
8.
Wojtuszkiewicz, Anna, Gerrit Jan Schuurhuis, Floortje L. Kessler, et al.. (2016). Exosomes Secreted by Apoptosis-Resistant Acute Myeloid Leukemia (AML) Blasts Harbor Regulatory Network Proteins Potentially Involved in Antagonism of Apoptosis. Molecular & Cellular Proteomics. 15(4). 1281–1298. 80 indexed citations
9.
Franke, N., Gertjan J.L. Kaspers, Yehuda G. Assaraf, et al.. (2016). Exocytosis of polyubiquitinated proteins in bortezomib-resistant leukemia cells: a role for MARCKS in acquired resistance to proteasome inhibitors. Oncotarget. 7(46). 74779–74796. 17 indexed citations
10.
Franke, N., Gertjan J.L. Kaspers, Yehuda G. Assaraf, et al.. (2015). Marcks Marks Resistance to Proteasome Inhibitors: Exocytosis of Polyubiquitinated Proteins in Bortezomib-Resistant Leukemia Cells. Blood. 126(23). 3712–3712. 1 indexed citations
11.
Niewerth, Denise, Johan van Meerloo, Gerrit Jansen, et al.. (2014). Anti-leukemic activity and mechanisms underlying resistance to the novel immunoproteasome inhibitor PR-924. Biochemical Pharmacology. 89(1). 43–51. 38 indexed citations
12.
Niewerth, Denise, Gerrit Jansen, Johan van Meerloo, et al.. (2014). Antileukemic Activity and Mechanism of Drug Resistance to the Marine Salinispora tropica Proteasome Inhibitor Salinosporamide A (Marizomib). Molecular Pharmacology. 86(1). 12–19. 40 indexed citations
13.
Niewerth, Denise, Gertjan J.L. Kaspers, Yehuda G. Assaraf, et al.. (2014). Interferon-γ-induced upregulation of immunoproteasome subunit assembly overcomes bortezomib resistance in human hematological cell lines. Journal of Hematology & Oncology. 7(1). 7–7. 65 indexed citations
14.
Niewerth, Denise, N. Franke, Gerrit Jansen, et al.. (2013). Higher ratio immune versus constitutive proteasome level as novel indicator of sensitivity of pediatric acute leukemia cells to proteasome inhibitors. Haematologica. 98(12). 1896–1904. 54 indexed citations
15.
Niewerth, Denise, Johan van Meerloo, Yehuda G. Assaraf, et al.. (2013). The Novel Immunoproteasome Inhibitor PR-924: Anti-Leukemic Activity and Mechanisms Of Resistance. Blood. 122(21). 3841–3841. 1 indexed citations
16.
17.
Jansen, Gerrit, Yehuda G. Assaraf, Johan van Meerloo, et al.. (2011). Proteasome-based mechanisms of intrinsic and acquired bortezomib resistance in non-small cell lung cancer. Biochemical Pharmacology. 83(2). 207–217. 64 indexed citations
18.
Meerloo, Johan van, Gertjan J.L. Kaspers, & Jacqueline Cloos. (2011). Cell Sensitivity Assays: The MTT Assay. Methods in molecular biology. 731. 237–245. 1899 indexed citations breakdown →
19.
Franke, N., Denise Niewerth, Yehuda G. Assaraf, et al.. (2011). Impaired bortezomib binding to mutant β5 subunit of the proteasome is the underlying basis for bortezomib resistance in leukemia cells. Leukemia. 26(4). 757–768. 137 indexed citations
20.
Smeets, Serge, Tieneke B.M. Schaaij‐Visser, Johan van Meerloo, et al.. (2010). Immortalization of oral keratinocytes by functional inactivation of the p53 and pRb pathways. International Journal of Cancer. 128(7). 1596–1605. 75 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xuan Zhang Breakdown of academic impact, for papers by Lin Yang Breakdown of academic impact, for papers by Gianni Colotti Breakdown of academic impact, for papers by Yue Wang Breakdown of academic impact, for papers by Takahiro Mori Breakdown of academic impact, for papers by Huanjie Yang Breakdown of academic impact, for papers by Ann H. Cory Breakdown of academic impact, for papers by Anup K. Singh Breakdown of academic impact, for papers by Vito Ferro Breakdown of academic impact, for papers by Steve Weitman
Rankless by CCL
2026